RED CAT HOLDINGS INC (RCAT) Fundamental Analysis & Valuation

NASDAQ:RCAT • US75644T1007

15.36 USD
+0.28 (+1.86%)
At close: Mar 6, 2026
15.68 USD
+0.32 (+2.08%)
After Hours: 3/6/2026, 8:00:02 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This RCAT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

Overall RCAT gets a fundamental rating of 3 out of 10. We evaluated RCAT against 78 industry peers in the Aerospace & Defense industry. RCAT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. RCAT is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. RCAT Profitability Analysis

1.1 Basic Checks

  • In the past year RCAT has reported negative net income.
  • RCAT had a negative operating cash flow in the past year.
  • RCAT had negative earnings in each of the past 5 years.
  • RCAT had a negative operating cash flow in each of the past 5 years.
RCAT Yearly Net Income VS EBIT VS OCF VS FCFRCAT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M -30M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -24.57%, RCAT is doing worse than 75.64% of the companies in the same industry.
  • RCAT has a Return On Equity of -27.75%. This is in the lower half of the industry: RCAT underperforms 73.08% of its industry peers.
Industry RankSector Rank
ROA -24.57%
ROE -27.75%
ROIC N/A
ROA(3y)-36.1%
ROA(5y)-55.7%
ROE(3y)-39.94%
ROE(5y)-95.13%
ROIC(3y)N/A
ROIC(5y)N/A
RCAT Yearly ROA, ROE, ROICRCAT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K -1K 2K

1.3 Margins

  • RCAT does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RCAT Yearly Profit, Operating, Gross MarginsRCAT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. RCAT Health Analysis

2.1 Basic Checks

  • RCAT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, RCAT has more shares outstanding
  • RCAT has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for RCAT has been reduced compared to a year ago.
RCAT Yearly Shares OutstandingRCAT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
RCAT Yearly Total Debt VS Total AssetsRCAT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

  • RCAT has an Altman-Z score of 32.51. This indicates that RCAT is financially healthy and has little risk of bankruptcy at the moment.
  • RCAT has a better Altman-Z score (32.51) than 97.44% of its industry peers.
  • RCAT has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
  • RCAT's Debt to Equity ratio of 0.05 is amongst the best of the industry. RCAT outperforms 84.62% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Altman-Z 32.51
ROIC/WACCN/A
WACC9.58%
RCAT Yearly LT Debt VS Equity VS FCFRCAT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

2.3 Liquidity

  • RCAT has a Current Ratio of 10.42. This indicates that RCAT is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 10.42, RCAT belongs to the top of the industry, outperforming 94.87% of the companies in the same industry.
  • RCAT has a Quick Ratio of 9.14. This indicates that RCAT is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of RCAT (9.14) is better than 94.87% of its industry peers.
Industry RankSector Rank
Current Ratio 10.42
Quick Ratio 9.14
RCAT Yearly Current Assets VS Current LiabilitesRCAT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. RCAT Growth Analysis

3.1 Past

  • RCAT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -34.62%.
  • Looking at the last year, RCAT shows a very strong growth in Revenue. The Revenue has grown by 21.54%.
  • The Revenue has been growing by 176.68% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-34.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-90%
Revenue 1Y (TTM)21.54%
Revenue growth 3Y52.8%
Revenue growth 5Y176.68%
Sales Q2Q%64.95%

3.2 Future

  • Based on estimates for the next years, RCAT will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.51% on average per year.
  • The Revenue is expected to grow by 67.80% on average over the next years. This is a very strong growth
EPS Next Y-83.6%
EPS Next 2Y1.12%
EPS Next 3Y10.51%
EPS Next 5YN/A
Revenue Next Year111.71%
Revenue Next 2Y178.06%
Revenue Next 3Y115.19%
Revenue Next 5Y67.8%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
RCAT Yearly Revenue VS EstimatesRCAT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 50M 100M 150M 200M
RCAT Yearly EPS VS EstimatesRCAT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 -0.2 -0.4 -0.6

More info and screens

Find the best growth stocksShow best growing peers

0

4. RCAT Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for RCAT. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for RCAT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RCAT Price Earnings VS Forward Price EarningsRCAT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RCAT Per share dataRCAT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.12%
EPS Next 3Y10.51%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. RCAT Dividend Analysis

5.1 Amount

  • No dividends for RCAT!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

RCAT Fundamentals: All Metrics, Ratios and Statistics

RED CAT HOLDINGS INC

NASDAQ:RCAT (3/6/2026, 8:00:02 PM)

After market: 15.68 +0.32 (+2.08%)

15.36

+0.28 (+1.86%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)12-15
Earnings (Next)03-30
Inst Owners39.46%
Inst Owner Change-6.04%
Ins Owners11.75%
Ins Owner Change0.49%
Market Cap1.83B
Revenue(TTM)15.03M
Net Income(TTM)-70.28M
Analysts84
Price Target17.34 (12.89%)
Short Float %20.77%
Short Ratio1.75
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-57.08%
Min EPS beat(2)-86.27%
Max EPS beat(2)-27.88%
EPS beat(4)0
Avg EPS beat(4)-85.68%
Min EPS beat(4)-152.1%
Max EPS beat(4)-27.88%
EPS beat(8)1
Avg EPS beat(8)-96.13%
EPS beat(12)2
Avg EPS beat(12)-90.76%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-51.22%
Min Revenue beat(2)-59.15%
Max Revenue beat(2)-43.29%
Revenue beat(4)0
Avg Revenue beat(4)-35.68%
Min Revenue beat(4)-59.15%
Max Revenue beat(4)-6.87%
Revenue beat(8)1
Avg Revenue beat(8)-27.5%
Revenue beat(12)3
Avg Revenue beat(12)-22.84%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)13.33%
PT rev (3m)13.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)2.62%
EPS NY rev (1m)0%
EPS NY rev (3m)-42.64%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)14.34%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-45.21%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 121.96
P/FCF N/A
P/OCF N/A
P/B 7.24
P/tB 8.03
EV/EBITDA N/A
EPS(TTM)-0.7
EYN/A
EPS(NY)-0.39
Fwd EYN/A
FCF(TTM)-0.52
FCFYN/A
OCF(TTM)-0.51
OCFYN/A
SpS0.13
BVpS2.12
TBVpS1.91
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -24.57%
ROE -27.75%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-36.1%
ROA(5y)-55.7%
ROE(3y)-39.94%
ROE(5y)-95.13%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 58.06%
Cap/Sales 8.57%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 10.42
Quick Ratio 9.14
Altman-Z 32.51
F-Score4
WACC9.58%
ROIC/WACCN/A
Cap/Depr(3y)137.29%
Cap/Depr(5y)N/A
Cap/Sales(3y)10.59%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-34.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-90%
EPS Next Y-83.6%
EPS Next 2Y1.12%
EPS Next 3Y10.51%
EPS Next 5YN/A
Revenue 1Y (TTM)21.54%
Revenue growth 3Y52.8%
Revenue growth 5Y176.68%
Sales Q2Q%64.95%
Revenue Next Year111.71%
Revenue Next 2Y178.06%
Revenue Next 3Y115.19%
Revenue Next 5Y67.8%
EBIT growth 1Y-75.11%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-176.82%
EBIT Next 3Y-0.65%
EBIT Next 5Y21.72%
FCF growth 1Y-359.2%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-325.09%
OCF growth 3YN/A
OCF growth 5YN/A

RED CAT HOLDINGS INC / RCAT FAQ

Can you provide the ChartMill fundamental rating for RED CAT HOLDINGS INC?

ChartMill assigns a fundamental rating of 3 / 10 to RCAT.


What is the valuation status for RCAT stock?

ChartMill assigns a valuation rating of 0 / 10 to RED CAT HOLDINGS INC (RCAT). This can be considered as Overvalued.


Can you provide the profitability details for RED CAT HOLDINGS INC?

RED CAT HOLDINGS INC (RCAT) has a profitability rating of 0 / 10.


Can you provide the financial health for RCAT stock?

The financial health rating of RED CAT HOLDINGS INC (RCAT) is 6 / 10.


What is the earnings growth outlook for RED CAT HOLDINGS INC?

The Earnings per Share (EPS) of RED CAT HOLDINGS INC (RCAT) is expected to decline by -83.6% in the next year.